Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients.

• Whittam DH Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom. Electronic address: daniel.whittam@nhs.net.
• Cobo-Calvo A Pathologies de la Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer Hospices Civils de Lyon, Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle, INSERM U1028, CNRS UMR 5292, Lyon 1 University, Center for Research in Neuroscience of Lyon, Lyon, France.
• Lopez-Chiriboga AS Department of Neurology, Mayo Clinic, Rochester, Minnesota, United States.
• Pardo S Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States.
• Gornall M Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, United Kingdom.
• Cicconi S Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, United Kingdom.
• Brandt A Experimental and Clinical Research Center Max Delbrueck Center for Molecular Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
• Berek K Medical University of Innsbruck, Innsbruck, Austria.
• Berger T Department of Neurology, Medical University of Vienna, Vienna, Austria.
• Jelcic I UniversitätsSpital Zürich, Zürich, Switzerland.
• Gombolay G Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States; Emory & Children's Pediatric Institute, Atlanta, Georgia, United States.
• Oliveira LM Hospital das Clinicas Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
• Callegaro D Hospital das Clinicas Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
• Kaneko K Tohoku University Graduate School of Medicine, Sendai, Japan.
• Misu T Tohoku University Graduate School of Medicine, Sendai, Japan.
• Capobianco M Neurology Dept. - Regional MS Centre, S. Luigi University Hospital, Orbassano, Italy.
• Gibbons E Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
• Karthikeayan V Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom.
• Brochet B CHU de Bordeaux & INSERM U 1215, University of Bordeaux, Bordeaux, France.
• Audoin B Aix Marseille University, APHM, Hôpital de La Timone, Marseille, France.
• Mathey G Nancy University Hospital and Inserm CIC 1433, Nancy, France.
• Laplaud D Nantes University Hospital, Nantes, France.
• Thouvenot E Hôpital Carémeau, Nimes University Hospital, Nimes, France.
• Cohen M Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, Nice, France.
• Tourbah A Reims University Hospital, University of Reims Champagne-Ardenne, Reims, LPN EA 2027, University of Paris VIII, Saint-Denis, France.
• Maillart E Pitié-Salpêtrière Hospital, APHP, Paris, France.
• Ciron J Poitiers University Hospital, Poitiers, France.
• Deschamps R Fondation A. De Rothschild, Paris, France.
• Biotti D University Hospital of Purpan, Toulouse, France.
• Rostasy K Department of Pediatric Neurology, Children's Hospital Datteln, University Witten/Herdecke, Witten, Germany.
• Neuteboom R Department of Paediatric Neurology, Erasmus MC-Sophia, Rotterdam, the Netherlands; Department of Neurology, MS Centre ErasMS, Erasmus MC, Rotterdam, the Netherlands.
• Hemingway C Department of Paediatric Neurology, Great Ormond Street Hospital for Children, London, United Kingdom.
• Forsyth R Institute of Neuroscience, Newcastle University, Newcastle, United Kingdom.
• Matiello M Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States.
• Webb S Department of Neurology, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
• Hunt D Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United Kingdom.
• Murray K Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United Kingdom.
• Hacohen Y Department of Paediatric Neurology, Great Ormond Street Hospital for Children, London, United Kingdom; Department of Neuroinflammation, Queen Square MS Centre, UCL Institute of Neurology, London, United Kingdom.
• Lim M Children's Neuroscience, Evelina London Children's Hospital @ Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
• Leite MI Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom.
• Palace J Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom.
• Solomon T Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
• Lutterotti A UniversitätsSpital Zürich, Zürich, Switzerland.
• Fujihara K Tohoku University Graduate School of Medicine, Sendai, Japan.
• Nakashima I Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
• Bennett JL Departments of Neurology and Ophthalmology, Program in Neuroscience, University of Colorado School of Medicine, Aurora, Colorado, United States.
• Pandit L Nitte University, Mangaluru, Karnataka, India.
• Chitnis T Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States.
• Weinshenker BG Department of Neurology, Mayo Clinic, Rochester, Minnesota, United States.
• Wildemann B Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.
• Sato DK Hospital das Clinicas Faculty of Medicine, University of São Paulo, São Paulo, Brazil; Tohoku University Graduate School of Medicine, Sendai, Japan; Pontificia Universidade Catolica Rio Grande Do Sul, Porto Alegre RS, Brazil.
• Kim SH Research Institute and Hospital of National Cancer Center, Goyang, South Korea.
• Huda S Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
• Kim HJ Research Institute and Hospital of National Cancer Center, Goyang, South Korea.
• Reindl M Medical University of Innsbruck, Innsbruck, Austria.
• Levy M Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States.
• Jarius S Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.
• Tenembaum S National Pediatric Hospital Dr. Juan P. Garrahan, Ciudad de Buenos Aires, Argentina.
• Paul F Experimental and Clinical Research Center Max Delbrueck Center for Molecular Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
• Pittock S Department of Neurology, Mayo Clinic, Rochester, Minnesota, United States.
• Marignier R Pathologies de la Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer Hospices Civils de Lyon, Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle, INSERM U1028, CNRS UMR 5292, Lyon 1 University, Center for Research in Neuroscience of Lyon, Lyon, France.
• Jacob A Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom; Department of Neurology, The Cleveland Clinic Abu Dhabi, United Arab Emirates. Electronic address: anu.jacob@thewaltoncentre.nhs.uk.

MOG

Myelin oligodendrocyte glycoprotein

Neuromyelitis optica

Optic neuritis

Rituximab